Clinical Trials Update from NCI National Cancer Institute sent this bulletin at 07/07/2016 05:29 PM EDT Having trouble viewing this email? View it as a Web page. Clinical Trials Updates from the National Cancer Institute Clinical Trials News New and Improved Clinical Trials Search Form Patients and their providers can now easily search for clinical trials using NCI’s newly streamlined clinical trials search form. Share Your Ideas about Clinical Trials Do you have ideas on how NCI can make information about cancer clinical trials more accessible to you? Visit this site between now and August 15 to tell us about them. Clinical Trials Information for Patients and Caregivers What Are Clinical Trials? Basic information that explains what clinical trials are and why they are critical to making progress against cancer. Newly Opened Clinical Trials Selected NCI-supported clinical trials that recently opened to new patients: Vaccine Therapy in Treating Patients with Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab Lenalidomide, Ibrutinib, and Rituximab in Treating Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Sorafenib Tosylate, Vorinostat, Gemcitabine Hydrochloride, and Radiation Therapy in Treating Patients with Pancreatic Cancer Pembrolizumab and Stereotactic Body Radiation Therapy in Treating Patients with Metastatic Melanoma or Non-small Cell Lung Cancer Nab-Paclitaxel with or without Carboplatin in Treating Elderly Patients with Stage IV Non-small Cell Lung Cancer Ceritinib in Treating Patients with Activated Gastrointestinal Malignancies That Cannot Be Removed by Surgery Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer). Sorafenib Tosylate and Irinotecan Hydrochloride in Treating Pediatric Patients with Recurrent or Refractory Solid Tumors mPCST in Reducing Pain and Disability in Patients with Breast Cancer from Medically Underserved Communities Ramucirumab and Somatostatin Analog Therapy in Treating Patients with Locally Advanced or Metastatic Carcinoid Tumor That Cannot Be Removed by Surgery
